Literature DB >> 26554150

Recent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and Imaging.

Micah D K Glasgow, Mahavir B Chougule.   

Abstract

Nanotechnology and combination therapy are two major fields that show great promise in the treatment of cancer. The delivery of drugs via nanoparticles helps to improve drug's therapeutic effectiveness while reducing adverse side effects associated wifh high dosage by improving their pharmacokinetics. Taking advantage of molecular markers over-expressing on tumor tissues compared to normal cells, an "active" molecular marker targeted approach would be-beneficial for cancer therapy. These actively targeted nanoparticles would increase drug concentration at the tumor site, improving efficacy while further reducing chemo-resistance. The multidisciplinary approach may help to improve the overall efficacy in cancer therapy. This review article summarizes recent developments of targeted multifunctional nanoparticles in the delivery, of various drugs for a combinational chemotherapy approach to cancer treatment and imaging.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26554150      PMCID: PMC4816444          DOI: 10.1166/jbn.2015.2145

Source DB:  PubMed          Journal:  J Biomed Nanotechnol        ISSN: 1550-7033            Impact factor:   4.099


  279 in total

Review 1.  Theranostics: combining imaging and therapy.

Authors:  Sneha S Kelkar; Theresa M Reineke
Journal:  Bioconjug Chem       Date:  2011-08-29       Impact factor: 4.774

2.  Asialoglycoprotein receptor targeted gene delivery using galactosylated polyethylenimine-graft-poly(ethylene glycol): in vitro and in vivo studies.

Authors:  Eun-Mi Kim; Hwan-Jeong Jeong; In-Kyu Park; Chong-Su Cho; Hyung-Bae Moon; Dae-Yeul Yu; Hee-Seung Bom; Myung-Hee Sohn; In-Joon Oh
Journal:  J Control Release       Date:  2005-10-25       Impact factor: 9.776

3.  High-flow microinfusion: tissue penetration and pharmacodynamics.

Authors:  P F Morrison; D W Laske; H Bobo; E H Oldfield; R L Dedrick
Journal:  Am J Physiol       Date:  1994-01

4.  Modified doxorubicin for improved encapsulation in PVA polymeric micelles.

Authors:  I Orienti; G Zuccari; A Fini; A M Rabasco; R Carosio; L Raffaghello; P G Montaldo
Journal:  Drug Deliv       Date:  2005 Jan-Feb       Impact factor: 6.419

Review 5.  Prevalent mutations in prostate cancer.

Authors:  Jin-Tang Dong
Journal:  J Cell Biochem       Date:  2006-02-15       Impact factor: 4.429

6.  A phase II study of paclitaxel poliglumex in combination with transdermal estradiol for the treatment of metastatic castration-resistant prostate cancer after docetaxel chemotherapy.

Authors:  Tomasz M Beer; Charles Ryan; Joshi Alumkal; Christopher W Ryan; Janine Sun; Kristine M Eilers
Journal:  Anticancer Drugs       Date:  2010-04       Impact factor: 2.248

7.  HPMA-based polymer conjugates with drug combination.

Authors:  Hana Krakovicová; Tomás Etrych; Karel Ulbrich
Journal:  Eur J Pharm Sci       Date:  2009-04-01       Impact factor: 4.384

8.  One-pot conversion of RAFT-generated multifunctional block copolymers of HPMA to doxorubicin conjugated acid- and reductant-sensitive crosslinked micelles.

Authors:  Zhongfan Jia; Lingjiun Wong; Thomas P Davis; Volga Bulmus
Journal:  Biomacromolecules       Date:  2008-10-10       Impact factor: 6.988

Review 9.  Nanocarriers as an emerging platform for cancer therapy.

Authors:  Dan Peer; Jeffrey M Karp; Seungpyo Hong; Omid C Farokhzad; Rimona Margalit; Robert Langer
Journal:  Nat Nanotechnol       Date:  2007-12       Impact factor: 39.213

Review 10.  Biological and clinical characterization of paclitaxel poliglumex (PPX, CT-2103), a macromolecular polymer-drug conjugate.

Authors:  Stewart D Chipman; Fred B Oldham; Gabriella Pezzoni; Jack W Singer
Journal:  Int J Nanomedicine       Date:  2006
View more
  26 in total

Review 1.  Epidrugs: targeting epigenetic marks in cancer treatment.

Authors:  Cristiana Libardi Miranda Furtado; Maria Claudia Dos Santos Luciano; Renan Da Silva Santos; Gilvan Pessoa Furtado; Manoel Odorico Moraes; Claudia Pessoa
Journal:  Epigenetics       Date:  2019-07-13       Impact factor: 4.528

2.  Synergistic anti-tumor effect of anti-PD-L1 antibody cationic microbubbles for delivery of the miR-34a gene combined with ultrasound on cervical carcinoma.

Authors:  Yun Liu; Jinjun Jiang; Chaoqi Liu; Wensi Zhao; Yao Ma; Zhiwei Zheng; Qing Zhou; Yun Zhao
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

3.  Aerosol Delivery of siRNA to the Lungs. Part 2: Nanocarrier-based Delivery Systems.

Authors:  Susanne R Youngren-Ortiz; Nishant S Gandhi; Laura España-Serrano; Mahavir B Chougule
Journal:  Kona       Date:  2016-04-30       Impact factor: 2.897

4.  Mechanism Investigation of Hyaluronidase-Combined Multistage Nanoparticles for Solid Tumor Penetration and Antitumor Effect.

Authors:  Enrui Chen; Shangcong Han; Bo Song; Lisa Xu; Haicheng Yuan; Mingtao Liang; Yong Sun
Journal:  Int J Nanomedicine       Date:  2020-08-24

5.  Rational Design of Polyglutamic Acid Delivering an Optimized Combination of Drugs Targeting Mutated BRAF and MEK in Melanoma.

Authors:  Evgeni Pisarevsky; Rachel Blau; Yana Epshtein; Dikla Ben-Shushan; Anat Eldar-Boock; Galia Tiram; Shani Koshrovski-Michael; Anna Scomparin; Sabina Pozzi; Adva Krivitsky; Gal Shenbach-Koltin; Eilam Yeini; Lidar Fridrich; Richard White; Ronit Satchi-Fainaro
Journal:  Adv Ther (Weinh)       Date:  2020-05-12

Review 6.  Potential Therapeutic Targets of Resveratrol, a Plant Polyphenol, and Its Role in the Therapy of Various Types of Cancer.

Authors:  Saleh A Almatroodi; Mohammed A Alsahli; Abdullah S M Aljohani; Fahad A Alhumaydhi; Ali Yousif Babiker; Amjad Ali Khan; Arshad Husain Rahmani
Journal:  Molecules       Date:  2022-04-21       Impact factor: 4.927

7.  A pH-Sensitive Prodrug Nanocarrier Based on Diosgenin for Doxorubicin Delivery to Efficiently Inhibit Tumor Metastasis.

Authors:  Zeliang Wei; Haibo Wang; Guang Xin; Zhi Zeng; Shiyi Li; Yue Ming; Xiaoyu Zhang; Zhihua Xing; Li Li; Youping Li; Boli Zhang; Junhua Zhang; Hai Niu; Wen Huang
Journal:  Int J Nanomedicine       Date:  2020-09-04

8.  Diffusion Reflection Method for Early Detection of Oral Squamous Cell Carcinoma Specifically Targeted by Circulating Gold-Nanorods Bio-Conjugated to Anti-Epidermal Growth Factor Receptor.

Authors:  Dror Fixler; Abraham Hirshberg; Shiran Sudri; Hamootal Duadi; Florin Altman; Irit Allon; Ariel Ashkenazy; Ruchira Chakraborty; Ilya Novikov
Journal:  Int J Nanomedicine       Date:  2021-03-17

9.  Tuftsin-Bearing Liposomes Co-Encapsulated with Doxorubicin and Curcumin Efficiently Inhibit EAC Tumor Growth in Mice.

Authors:  Padmapriya Srinivasan; Raghunandan Mahadeva; Kalaimathi Murugesan; Chhitar M Gupta; Wahajul Haq
Journal:  Int J Nanomedicine       Date:  2020-12-31

Review 10.  Recent Advances on Immune Targeted Therapy of Colorectal Cancer Using bi-Specific Antibodies and Therapeutic Vaccines.

Authors:  Ali Azadi; Alireza Golchini; Sina Delazar; Fatemeh Abarghooi Kahaki; Seyed Mohsen Dehnavi; Zahra Payandeh; Shirin Eyvazi
Journal:  Biol Proced Online       Date:  2021-07-01       Impact factor: 3.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.